Advertisement
Advertisement
CUE
Cue Biopharma Inc
1.07
USD+0.01
+0.94%
Dec 18, 15:59 UTC -5
Closed
...
Cue Biopharma Inc Profile
About
Info & Links
CEO
Daniel R. Passeri
Headquarters
BOSTON, MA 02135, UNITED STATES
Industry
Sector
Website
Auditor
RSM US LLP
Share holders
86
Employees
53
Cue Biopharma Inc Statistics
Valuation Measures
Market Capitalization2
67.78M
Enterprise Value
40.66M
Enterprise Value/EBITDA(ttm)
-0.90
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
6.25
Price to Book(mrq)
2.23
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
100.00%
Operating Margin(ttm)
-468.02%
Profit Margin(ttm)
-524.77%
Return on Equity(ttm)
-156.38%
Return on Invested Capital(ttm)
-144.62%
Return on Assets(ttm)
-88.07%
Income Statement
Revenue(ttm)
9.53M
Revenue Per Share(ttm)
0.15
Gross Profit(ttm)
9.53M
EBITDA(ttm)3
-45.25M
Net Income Available to Common(ttm)
-44.61M
Diluted EPS(ttm)
-0.90
Share Statistics
Beta (5Y Monthly)
1.66
52-Week Change
-59.00%
S&P 500 52-Week Change
23.87%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
63.35M
Dividend Yield
0.00%
Float4
55.58M
% Held by Insiders
12.26%
% Held by Institutions
35.04%
Balance Sheet
Total Cash(mrq)
32.42M
Total Cash Per Share(mrq)
0.51
Total Debt(mrq)
5.29M
Total Debt/Equity(mrq)
20.86%
Current Ratio(mrq)
2.22%
Quick Ratio(mrq)
2.22%
Book Value Per Share(mrq)
0.42
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.53
Free Cash Flow(ytd)
-27.27M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement